Literature DB >> 10867218

Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.

J C de la Torre1.   

Abstract

This review discusses the experimental and clinical data which indicate that chronic cerebral hypoperfusion can affect metabolic, anatomic, and cognitive function adversely. In aged but not young animals, chronic brain hypoperfusion results in regional pre- and post-synaptic changes, protein synthesis abnormalities, energy metabolic dysregulation, reduced glucose utilization, cholinergic receptor loss, and visuo-spatial memory deficits. Additionally, aging animals that are kept for prolonged periods of time after chronic brain hypoperfusion, also develop brain capillary degeneration in CA1 hippocampus and neuronal damage extending from the hippocampal region to the temporo-parietal cortex where neurodegenerative tissue atrophy eventually forms. All these pathologic events occur in rodents in the absence of senile plaques and neurofibrillary tangles. Alzheimer brains reveal similar biochemical and structural changes as those experimentally induced in aging animals. Moreover, regional cerebral hypoperfusion is one of the earlier (if not the earliest) clinical manifestations in both the sporadic and familial forms of Alzheimer's disease. In addition, therapy that improves or increases cerebral perfusion is generally of some benefit to Alzheimer patients. Conversely, a variety of disorders with different etiologies that impair or diminish cerebral perfusion are reported to be risk factors for this dementia. These findings have prompted us to propose the concept that advanced aging in the presence of a vascular risk factor can converge to create a critically attained threshold of cerebral hypoperfusion (CATCH) that triggers regional brain microcirculatory disturbances and impairs optimal delivery of energy substrates needed for normal brain cell function. The outcome of this defect generates a chain of events leading to the progressive evolution of brain metabolic, cognitive and tissue pathology that characterize Alzheimer's disease. The possible role of CATCH in familial and early onset Alzheimer's disease is briefly discussed from a theoretical vantagepoint. The growing and most recent evidence in support of the CATCH concept is the focus of this review.

Entities:  

Mesh:

Year:  2000        PMID: 10867218     DOI: 10.1016/s0197-4580(00)00111-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  70 in total

Review 1.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

2.  S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Balasubramaniam Annamalai; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-08-10       Impact factor: 3.252

3.  Psychosis post corona radiata and lentiform nucleus infarction.

Authors:  Khadijah Hasanah Abang Abdullah; Suriati Mohamed Saini; Shalisah Sharip; Abdul Hamid Abdul Rahman
Journal:  BMJ Case Rep       Date:  2015-04-02

4.  Alzheimer's dementia by circulation disorders: when trees hide the forest.

Authors:  Carlos G Dotti; Bart De Strooper
Journal:  Nat Cell Biol       Date:  2009-02       Impact factor: 28.824

5.  Hypertension is associated with cognitive decline in elderly people at high risk for dementia.

Authors:  Michael Wysocki; Xiaodong Luo; James Schmeidler; Karen Dahlman; Gerson T Lesser; Hillel Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

6.  The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population.

Authors:  Hazel I Zonneveld; Elizabeth A Loehrer; Albert Hofman; Wiro J Niessen; Aad van der Lugt; Gabriel P Krestin; M Arfan Ikram; Meike W Vernooij
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

Review 7.  Impact of the CD40-CD40L dyad in Alzheimer's disease.

Authors:  Brian Giunta; Kavon Rezai-Zadeh; Jun Tan
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

8.  Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.

Authors:  Thomas Simon O'Hagan; Whitney Wharton; Patrick Gavin Kehoe
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 9.  [Alzheimer Disease].

Authors:  Fadi Massoud
Journal:  Can Fam Physician       Date:  2007-01       Impact factor: 3.275

10.  SOLUBLE CD40 LIGAND IN DEMENTIA.

Authors:  B Giunta; K P Figueroa; T Town; J Tan
Journal:  Drugs Future       Date:  2009-04-01       Impact factor: 0.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.